Description
Temozolomide, an alkylating agent, is an oral chemotherapy drug used to treat an aggressive brain tumor called, Grade IV astrocytoma, and to treat melanoma skin cancer. Ungraded products supplied by TCI America are generally suitable for common industrial uses or for research purposes but typically are not suitable for human consumption or therapeutic use.
Safety Data Sheet